PA
SHOO icon

PharVision Advisers’s Steven Madden SHOO Stock Holding History

PharVision Advisers’s Portfolio SHOO Stock Details SHOO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-5,319
Closed -$226K – 491
2024
Q4 		$226K Buy
+5,319
New +$240K 0.19% 253

Other funds holding SHOO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

PharVision Advisers's SHOO Position: Q1 2025 in Review

PharVision Advisers sold out of Steven Madden (SHOO) in Q1 2025, closing a stake of 5,319 shares — an estimated $226K sold.

PharVision Advisers first reported a position in SHOO in Q4 2024 and held it in 1 quarter. The position peaked at $226K in Q4 2024. 278 funds tracked by Wall St. Rank hold SHOO as of Q1 2025.

  • PharVision Advisers reported no remaining Steven Madden position as of Q1 2025 after selling out during the quarter.
  • PharVision Advisers sold 5,319 Steven Madden shares in Q1 2025, an estimated $226K.
  • PharVision Advisers first reported a position in Steven Madden in Q4 2024 and held it in 1 quarter.
  • PharVision Advisers's Steven Madden position peaked at $226K in Q4 2024.
  • 278 funds tracked by Wall St. Rank held Steven Madden as of Q1 2025.

Based on PharVision Advisers's 13F filing for Q1 2025, filed 15 May 2025.